Stay updated with breaking news from Advanced Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Biden administration on Saturday put Johnson & Johnson in charge of a Baltimore manufacturing plant that ruined 15 million doses of its COVID-19 vaccine, and stopped the facility from making another vaccine developed by AstraZeneca.
An Emergent BioSolutions facility on Thursday in Baltimore. Tasos Katopodis/Getty Images Johnson & Johnson is reporting a setback in its effort to produce tens of millions of COVID-19 vaccine doses, saying a contract production plant in Baltimore produced an ingredient that failed quality control tests. The material was made by Emergent BioSolutions, according to Johnson & Johnson. Johnson & Johnson says the issue "was identified and addressed with Emergent," adding that it also informed the U.S. Food and Drug Administration. The drug company says the problem involved one batch of...
Johnson & Johnson Says Contractor Botched Part Of Vaccine Production at 8:41 am NPR Johnson & Johnson is reporting a setback in its effort to produce tens of millions of COVID-19 vaccine doses, saying a contract production plant in Baltimore produced an ingredient that failed quality control tests. The material was made by Emergent BioSolutions, according to Johnson & Johnson. Johnson & Johnson says the issue "was identified and addressed with Emergent," adding that it also informed the U.S. Food and Drug Administration. The drug company says the problem involved one batch ...
SCSI Trade Association Announces 2021 Board of Directors as Storage Industry Transitions to 24G SAS Technology Cameron T. Brett, Director of Enterprise Marketing at KIOXIA America, Inc. Re-elected for Third Term as STA President News provided by Share this article Share this article SAN FRANCISCO, March 10, 2021 /PRNewswire/ -- The SCSI Trade Association (STA), a globally recognized authority on Serial Attached SCSI (SAS) technology used in data storage interconnects, today announced its 2021 Board of Directors. These dynamic leaders in the storage industry are charged with developing strate...
Mar 8, 2021 10:23am There's a ready market for viral vectors. Matica, a new CDMO and a subsidiary of South Korea-based CHA Biotech, will soon be poised to help meet the demand. (Harvard University) A lack of global capacity to produce cell and gene therapies has been exacerbated by an even more pressing need: to develop and manufacture coronavirus vaccines. So it appears the timing is right for Matica Biotechnology, a developer and producer of viral vectors, to put down roots in the United States. The brand-new CDMO has teamed up with Texas A&M University and its advanced manufacturing center...